HUP0104113A2 - Eljárás interferon izoformok konvertálására és termékeik - Google Patents

Eljárás interferon izoformok konvertálására és termékeik

Info

Publication number
HUP0104113A2
HUP0104113A2 HU0104113A HUP0104113A HUP0104113A2 HU P0104113 A2 HUP0104113 A2 HU P0104113A2 HU 0104113 A HU0104113 A HU 0104113A HU P0104113 A HUP0104113 A HU P0104113A HU P0104113 A2 HUP0104113 A2 HU P0104113A2
Authority
HU
Hungary
Prior art keywords
methods
conversion
products
desired protein
isoforms
Prior art date
Application number
HU0104113A
Other languages
English (en)
Inventor
Susan Cannon-Carlson
Andres Frei
Seoju Lee
Roland Mengisen
Marcio Voloch
David C. Wylie
Original Assignee
Schering Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp. filed Critical Schering Corp.
Publication of HUP0104113A2 publication Critical patent/HUP0104113A2/hu
Publication of HUP0104113A3 publication Critical patent/HUP0104113A3/hu
Publication of HU228265B1 publication Critical patent/HU228265B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A találmány tárgya eljárások fehérjék kísérő izoformjainak izolálásáraés a kívánt fehérjévé konvertálására. Az előnyös megvalósításokbansavas oldatok vagy cinkoldatok használatával egy kémiai csoportothasítanak le a kívánt fehérjéről. További előnyös megvalósításokban akémiai csoport lehasítása után a redukált szulfhidrilcsoportokatoxidálják, hogy a kívánt fehérje funkcióképes formáját kapják meg. Ó
HU0104113A 1998-11-12 1999-10-05 Methods of conversion of interferon isoforms and products thereof HU228265B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19054298A 1998-11-12 1998-11-12
PCT/US1999/020900 WO2000029440A1 (en) 1998-11-12 1999-10-05 Methods of conversion of interferon isoforms and products thereof

Publications (3)

Publication Number Publication Date
HUP0104113A2 true HUP0104113A2 (hu) 2002-03-28
HUP0104113A3 HUP0104113A3 (en) 2004-04-28
HU228265B1 HU228265B1 (en) 2013-02-28

Family

ID=22701766

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104113A HU228265B1 (en) 1998-11-12 1999-10-05 Methods of conversion of interferon isoforms and products thereof

Country Status (27)

Country Link
EP (2) EP1894944B1 (hu)
JP (3) JP4468585B2 (hu)
KR (1) KR100922454B1 (hu)
CN (2) CN100390197C (hu)
AR (1) AR023906A1 (hu)
AT (2) ATE409706T1 (hu)
AU (1) AU766309B2 (hu)
BR (1) BR9915257A (hu)
CA (1) CA2348739C (hu)
CY (2) CY1110444T1 (hu)
CZ (2) CZ303110B6 (hu)
DE (2) DE69939657D1 (hu)
DK (2) DK1894944T3 (hu)
ES (2) ES2315019T3 (hu)
HK (2) HK1112746A1 (hu)
HU (1) HU228265B1 (hu)
ID (1) ID28552A (hu)
IL (2) IL142546A0 (hu)
NO (2) NO329483B1 (hu)
NZ (1) NZ511074A (hu)
PL (2) PL200274B1 (hu)
PT (2) PT1129111E (hu)
SI (2) SI1894944T1 (hu)
SK (2) SK287564B6 (hu)
TW (1) TW577894B (hu)
WO (1) WO2000029440A1 (hu)
ZA (1) ZA200103010B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4468585B2 (ja) * 1998-11-12 2010-05-26 シェーリング コーポレイション インターフェロンアイソフォームおよびその産物の変換の方法
JP2012513200A (ja) * 2008-12-23 2012-06-14 シェーリング コーポレイション 組換え製造インターフェロンの精製

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530901A (en) 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
IE54096B1 (en) 1980-01-08 1989-06-21 Biogen Nv Dn sequences, recombinant dna molecules and processes for producing human interferon - like polypeptides
US4315852A (en) 1980-11-26 1982-02-16 Schering Corporation Extraction of interferon from bacteria
US4364863A (en) * 1980-12-29 1982-12-21 Schering Corporation Extraction of interferon from bacteria
EP0082481B2 (en) 1981-12-23 1990-09-12 Schering Corporation Stabilised alpha-interferon formulations and their preparation
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
US4847079A (en) 1985-07-29 1989-07-11 Schering Corporation Biologically stable interferon compositions comprising thimerosal
US4732683A (en) 1986-12-02 1988-03-22 Biospectrum, Inc. Purification method for alpha interferon
US4765903A (en) 1987-10-06 1988-08-23 Interferon Sciences, Inc. Purification of monomeric interferon
US5272135A (en) 1991-03-01 1993-12-21 Chiron Ophthalmics, Inc. Method for the stabilization of methionine-containing polypeptides
AU648214B2 (en) * 1991-12-31 1994-04-14 Lucky Limited Recombinant gene coding for human alpha interferon and expression vector thereof, etc.
ES2161793T3 (es) * 1994-04-09 2001-12-16 Hoffmann La Roche Proceso para la produccion de alfa-interferona.
US5766582A (en) 1994-10-11 1998-06-16 Schering Corporation Stable, aqueous alfa interferon solution formulations
JP4468585B2 (ja) * 1998-11-12 2010-05-26 シェーリング コーポレイション インターフェロンアイソフォームおよびその産物の変換の方法

Also Published As

Publication number Publication date
HU228265B1 (en) 2013-02-28
JP2002530291A (ja) 2002-09-17
NO20012327L (no) 2001-05-11
DK1129111T3 (da) 2009-01-05
KR100922454B1 (ko) 2009-10-21
HK1112746A1 (en) 2008-09-12
ES2348104T3 (es) 2010-11-30
EP1894944B1 (en) 2010-08-04
ATE476445T1 (de) 2010-08-15
HUP0104113A3 (en) 2004-04-28
BR9915257A (pt) 2001-08-07
CY1110444T1 (el) 2015-04-29
CA2348739A1 (en) 2000-05-25
DE69942655D1 (de) 2010-09-16
NO20100775L (no) 2001-05-11
NO329483B1 (no) 2010-10-25
CN1326465A (zh) 2001-12-12
CN101255188A (zh) 2008-09-03
IL142546A (en) 2013-07-31
AU6387099A (en) 2000-06-05
EP1894944A1 (en) 2008-03-05
JP2010209117A (ja) 2010-09-24
AR023906A1 (es) 2002-09-04
AU766309B2 (en) 2003-10-16
CZ20011303A3 (cs) 2001-08-15
ID28552A (id) 2001-05-31
PL201341B1 (pl) 2009-04-30
PT1894944E (pt) 2010-10-28
WO2000029440A1 (en) 2000-05-25
NZ511074A (en) 2003-10-31
CN100390197C (zh) 2008-05-28
CZ302402B6 (cs) 2011-05-04
CY1110794T1 (el) 2015-06-10
SI1894944T1 (sl) 2010-11-30
JP4468585B2 (ja) 2010-05-26
EP1129111B1 (en) 2008-10-01
SI1129111T1 (sl) 2009-06-30
SK6172001A3 (en) 2001-10-08
PL200274B1 (pl) 2008-12-31
PL348162A1 (en) 2002-05-06
ATE409706T1 (de) 2008-10-15
DE69939657D1 (de) 2008-11-13
PT1129111E (pt) 2008-12-22
ZA200103010B (en) 2002-07-11
TW577894B (en) 2004-03-01
EP1129111A1 (en) 2001-09-05
SK287564B6 (sk) 2011-02-04
KR20010080336A (ko) 2001-08-22
IL142546A0 (en) 2002-03-10
SK287372B6 (sk) 2010-08-09
CA2348739C (en) 2010-05-11
CZ303110B6 (cs) 2012-04-04
HK1035544A1 (en) 2001-11-30
JP2006348056A (ja) 2006-12-28
NO331699B1 (no) 2012-02-27
ES2315019T3 (es) 2009-03-16
DK1894944T3 (da) 2010-10-18
NO20012327D0 (no) 2001-05-11

Similar Documents

Publication Publication Date Title
DE68911299T3 (de) Enzymelektrode und verfahren zur herstellung.
DE68919024T2 (de) Verfahren und Prozessor zur Abtastumsetzung.
ATE235887T1 (de) Verwendung von wässerigen arzneimittelzubereitungen zur erzeugung treibgasfreier aerosole
IT1295970B1 (it) Metodo di sequenziazione di oggetti postali.
DE69822307D1 (de) Menschliches adamts-1 protein, gen , welches für dieses kodiert, pharmazeutische zusammensetzung und verfahrem zur immunologischen bestimmung von menschlichen adamts-1 proteinen
DE3681966D1 (de) Oxydationskatalysatoren der perovskitgruppe und verfahren zur herstellung.
DE59601822D1 (de) Verfahren zur herstellung von weizenproteinhydrolysaten
DE69709649D1 (de) Nachspülzusätze sowie verfahren zur verwendung zur freisetzung von parfümvorstufen
SE8801701D0 (sv) Production technology based on enzymic method
ATE457354T1 (de) Für ein a. thaliana protein kodierende dna- sequenz mit delta-5,7-sterol-delta-7- reduktaseaktivität, das protein, verfahren zur herstellung, transformierte hefe-stämme und verwendungen
DE3681803D1 (de) Folienartige struktur und verfahren zur herstellung derselben.
DE3750779T2 (de) Enzym-Sensor und Verfahren zur Herstellung desselben.
DE3778089D1 (de) Verfahren zur herstellung und verwendung fester, pflanzenwirksamer zusammensetzungen.
DE3789833T2 (de) Isoliertes Phenylalanindehydrogenase-Gen und Verfahren zur Herstellung von Phenylalanindeshydrogenase.
DE3680139D1 (de) Kontinuierliches verfahren zur enzymatischen herstellung von isomaltulose.
ATE107162T1 (de) Schweisshemmende mittel und verfahren zur herstellung.
HUP0104113A2 (hu) Eljárás interferon izoformok konvertálására és termékeik
DE68917154D1 (de) C-terminus-amidierungsenzym-zusammensetzung, verfahren zur herstellung und verwendung.
DE3875359D1 (de) Dipeptide, verfahren zur herstellung und verwendung in der bestimmung von proteasen.
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
DE3767745D1 (de) Verfahren zur ph-pufferung.
DE68913394D1 (de) Verfahren zur Herstellung von substituierten Phenoxyethylaminen sowie Zwischenverbindungen.
DE3764855D1 (de) Mittel zur wachstumsfoerderung der haare.
DE3878296T2 (de) Rekombinante menschliche glutathionperoxidase, verfahren zur herstellung des enzyms und dafuer kodierende dna.
DE69627856D1 (de) PHENYLACETYL-CoA-LIGASE AUS PENICILLIUM CHRYSOGENUM

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: MERCK SHARP & DOHME CORP., US

Free format text: FORMER OWNER(S): SCHERING CORP., US